Biotechnology Innovation Organization’s Post

Since the passage of the #IRA, companies, investors, and patients have raised concerns about how the legislation will impact innovation. Meenakshi Datta talks about the latest regulatory guidance and strategy from leaders in the industry to prepare for the evolving landscape. #BIF23

María Eugenia Díaz Escanero

International Business Development & Sales | Partnerships | Deals | Strategy | Biotech | Pharma | Railways |

1y

Thanks for sharing your insights Meenakshi Datta !

Like
Reply

To view or add a comment, sign in

Explore topics